This is a non-core endpoint: only basic statistics are computed.
Complications following infusion, transfusion and therapeutic injection
ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
455
Check minimum number of events None
455
Include endpoints None
455
Remove individuals based on genotype QC
438
ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC
Control definitions
Control exclude
ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T8
Name in latin
Complicationes infusionis, transfusionis sive injectionis therapeuticae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Complications following infusion, transfusion and therapeutic injection
based on the number of shared cases.
Broader endpoints:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 438 | 260 | 178 |
| Unadjusted prevalence (%) | 0.11 | 0.11 | 0.10 |
| Mean age at first event (years) | 55.82 | 53.73 | 58.87 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC – Complications following infusion, transfusion and therapeutic injection
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Complications following infusion, transfusion and therapeutic injection
↥Endpoint not on priority list, no data to show.